The role of kinetic context in apparent biased agonism at GPCRs.

Klein Herenbrink C, Sykes DA, Donthamsetti P, Canals M, Coudrat T, Shonberg J, Scammells PJ, Capuano B, Sexton PM, Charlton SJ, Javitch JA, Christopoulos A, Lane JR. · 2016

Read The role of kinetic context in apparent biased agonism at GPCRs. by Klein Herenbrink C, Sykes DA, Donthamsetti P, Canals M, Coudrat T, Shonberg J, Scammells PJ, Capuano B, Sexton PM, Charlton SJ, Javitch JA, Christopoulos A, Lane JR. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4770093.txt.

Description

Carmen Klein Herenbrink leads a large author team in Nature Communications in 2016 with a caution on how drug bias is measured. Some drugs grip a cell receptor in a way that favors one inner signal path over another, a trait called biased agonism. Drug hunters prize it, since favored paths may heal while spared paths cause side effects.

Working with the dopamine D2 receptor, the team shows timing can fool the reading. How fast a drug binds and lets go, set against how fast each signal path rises and fades, can create the look of bias, or even flip its direction. What looks like a drug property may be a property of the test. The authors urge that binding speed be counted in any bias study design and reading.

Catalog record

CREATORKlein Herenbrink C, Sykes DA, Donthamsetti P, Canals M, Coudrat T, Shonberg J, Scammells PJ, Capuano B, Sexton PM, Charlton SJ, Javitch JA, Christopoulos A, Lane JR.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE72 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4770093

Browse the full library · About the Tower of Babel